Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: Mechanistic evidence to support RALES

Circulation

Volumn 102, Issue 19 SUPPL., 2000, Pages 2325-2328

  Bauersachs, J ^a   Fraccarollo, D ^a   Ertl, G ^a   Gretz, N ^a   Wehling, M ^a   Christ, M ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Angiotensin; Heart failure; Kidney; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID; PLACEBO; SPIRONOLACTONE; TRANDOLAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; ELECTROLYTE BALANCE; ENZYME INHIBITION; HEART LEFT VENTRICLE CONTRACTILITY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RISK BENEFIT ANALYSIS; SODIUM ABSORPTION; SODIUM EXCRETION; URINE VOLUME;

EID: 0034619571     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.19.2325     Document Type: Article

References (26)

1. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
2. Spironotactone in the long-term management of patients with congestive heart failure
3. The management of chronic heart failure
4. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
6. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
7. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldo-steronism
8. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
9. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
10. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])
11. Aldosterone and spironolactone in heart failure
12. Aldosterone in congestive heart failure: Analysis of determinants and role in sodium retention
13. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
14. Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation
15. Low-NaCl diet increases H-K-ATPase in intercalated cells from rat cortical collecting duct
16. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats
17. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril
18. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
19. Angiotensin II: A powerful controller of sodium transport in the early proximal tubule
20. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis
21. The renin angiotensin aldosterone system and frusemide response in congestive heart failure
22. Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure
23. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats
24. Diuretic complications
25. 2 kinin receptor within the plasma membrane of native endothelial cells
26. Treatment with cilazapril, angiotensin-converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat